Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP276789.RAWmRt5YvQwUHL4PaCGcJjU-8RkL71gqEyPdufupZz1Wc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP276789.RAWmRt5YvQwUHL4PaCGcJjU-8RkL71gqEyPdufupZz1Wc130_assertion type Assertion NP276789.RAWmRt5YvQwUHL4PaCGcJjU-8RkL71gqEyPdufupZz1Wc130_head.
- NP276789.RAWmRt5YvQwUHL4PaCGcJjU-8RkL71gqEyPdufupZz1Wc130_assertion description "[MN/CA9 gene expression was detected in 53/59 (89.8%) pleural effusions from cancer patients (15/16 for breast cancers, 10/11 for lung cancers, 4/4 for ovary cancers, 2/3 for colon-rectal cancers, 5/6 for cancers of unknown site, 7/8 for mesothelioma and 10/11 for other cancers).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP276789.RAWmRt5YvQwUHL4PaCGcJjU-8RkL71gqEyPdufupZz1Wc130_provenance.
- NP276789.RAWmRt5YvQwUHL4PaCGcJjU-8RkL71gqEyPdufupZz1Wc130_assertion evidence source_evidence_literature NP276789.RAWmRt5YvQwUHL4PaCGcJjU-8RkL71gqEyPdufupZz1Wc130_provenance.
- NP276789.RAWmRt5YvQwUHL4PaCGcJjU-8RkL71gqEyPdufupZz1Wc130_assertion SIO_000772 17536770 NP276789.RAWmRt5YvQwUHL4PaCGcJjU-8RkL71gqEyPdufupZz1Wc130_provenance.
- NP276789.RAWmRt5YvQwUHL4PaCGcJjU-8RkL71gqEyPdufupZz1Wc130_assertion wasDerivedFrom befree-20150227 NP276789.RAWmRt5YvQwUHL4PaCGcJjU-8RkL71gqEyPdufupZz1Wc130_provenance.
- NP276789.RAWmRt5YvQwUHL4PaCGcJjU-8RkL71gqEyPdufupZz1Wc130_assertion wasGeneratedBy ECO_0000203 NP276789.RAWmRt5YvQwUHL4PaCGcJjU-8RkL71gqEyPdufupZz1Wc130_provenance.